As one of the well-established pro-cancer interactions of BIRC5 is its binding with the Hsp90 [44], we now propose that it is likely that this protein–protein interaction is preserved while BIRC5 participates in the protein corona of nanocomposites. The gene discussed is BIRC5; the disease is cancer.